Search Results 251-260 of 13172 for pharmacogenetics
John R. Hawse, Ph.D., at Mayo Clinic studies hormone receptors in normal and diseased tissues, characterizes drivers of breast and ovarian cancers, ...
Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.
New imaging procedures, such as fluorine F 18 fluorodopa-labeled PET scans, may help in guiding surgery and radiation therapy and allow doctors to plan better ...
WEE1 inhibitor AZD1775 may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as ...
Nilufer Ertekin-Taner, M.D., Ph.D., who leads Mayo Clinic's Precision Medicine in Neurodegeneration Lab, studies complex genetic interactions in Alzheimer's ...
ROCHESTER, Minn. — Mayo Clinic researchers have discovered a key reason some cancer patients relapse after receiving chimeric antigen receptor T-cell therapy, ...
To learn more about the research interests of individual faculty members in the Department of Biochemistry and Molecular Biology, including their location, ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Last chance! Your gift today has 5X the power to fuel medical progress using AI.